Hospital
Vicksburg Healthcare LLC
Vicksburg Healthcare LLC was paid $23.04M by Medicaid between Jan 2018 and Dec 2024, across 279 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoVICKSBURG HEALTHCARE LLC
VICKSBURG, MS 39183
VICKSBURG, MS 39183
33aNPI1215981303assigned 05/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.04M
24GClaims709,674
24DCodes billed279
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#23 of 77
Median peer was paid$8.23M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 130,109 | $4.41M | |
| 2019 | 113,143 | $4.00M | |
| 2020 | 87,543 | $2.72M | |
| 2021 | 88,170 | $2.82M | |
| 2022 | 104,089 | $3.14M | |
| 2023 | 103,535 | $3.24M | |
| 2024incomplete | 83,085 | $2.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 33,094 | 27,185 | $4.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 21,556 | 17,251 | $3.97M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.4% | 8,868 | 7,126 | $1.72M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 8,808 | 7,577 | $815K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 9,350 | 7,666 | $746K |
| G0378 | Hospital observation service, per hour | 3.1% | 1,863 | 1,435 | $706K |
| 71046 | Radiologic examination, chest; 2 views | 2.5% | 12,813 | 10,896 | $576K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 3,370 | 2,878 | $515K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.1% | 13,880 | 2,845 | $483K |
| 87428 | 2.1% | 9,513 | 8,146 | $483K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 2,659 | 2,393 | $463K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 9,213 | 7,135 | $391K |
267 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 11,347 | $385K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 6,251 | $333K |
| 86900 | 1.2% | 5,073 | $279K | |
| 71045 | Radiologic examination, chest; single view | 1.2% | 8,333 | $276K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 2,479 | $244K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,849 | $222K |
| 80053 | Comprehensive metabolic panel | <1% | 29,695 | $216K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,525 | $209K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,462 | $209K |
| D0272 | Bitewings - two radiographic images | <1% | 446 | $189K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,511 | $187K |
| 36415 | Collection of venous blood by venipuncture | <1% | 71,178 | $179K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33,308 | $168K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,496 | $166K |
| 87590 | <1% | 8,172 | $158K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,168 | $147K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,467 | $146K |
| 87490 | <1% | 8,172 | $137K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 10,513 | $128K |
| 74022 | <1% | 1,855 | $126K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,155 | $115K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 289 | $114K |
| 86850 | <1% | 4,289 | $108K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,203 | $99K |
| 80061 | Lipid panel | <1% | 9,173 | $95K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,644 | $90K |
| 86901 | <1% | 5,068 | $86K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,049 | $84K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 993 | $83K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 785 | $79K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13,237 | $79K |
| 59025 | Fetal non-stress test | <1% | 722 | $78K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,731 | $77K |
| 62323 | <1% | 363 | $75K | |
| 74018 | <1% | 1,663 | $70K | |
| 85027 | <1% | 13,098 | $68K | |
| 83880 | <1% | 3,095 | $62K | |
| 84484 | <1% | 7,549 | $57K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 755 | $57K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,405 | $56K |
| 81025 | <1% | 9,547 | $56K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,255 | $54K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 994 | $52K |
| 72100 | <1% | 1,001 | $49K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,648 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,200 | $46K |
| 73562 | <1% | 1,273 | $45K | |
| 64493 | <1% | 114 | $44K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,010 | $44K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,071 | $43K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 880 | $43K |
| 88142 | <1% | 2,564 | $42K | |
| 84702 | <1% | 3,862 | $41K | |
| 73030 | <1% | 1,101 | $41K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,423 | $39K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 83 | $35K |
| 81001 | <1% | 16,073 | $34K | |
| 73630 | <1% | 816 | $33K | |
| 97161 | <1% | 724 | $30K | |
| 73130 | <1% | 762 | $30K | |
| 83690 | <1% | 6,166 | $30K | |
| 87807 | <1% | 2,671 | $28K | |
| 84439 | <1% | 4,027 | $28K | |
| 87340 | <1% | 3,720 | $27K | |
| 64635 | <1% | 39 | $26K | |
| 87040 | <1% | 3,784 | $26K | |
| 73610 | <1% | 652 | $25K | |
| 83735 | <1% | 6,219 | $24K | |
| 87077 | <1% | 3,847 | $23K | |
| 82677 | <1% | 1,265 | $23K | |
| 87186 | <1% | 3,413 | $21K | |
| 85007 | <1% | 6,678 | $21K | |
| 86762 | <1% | 2,056 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 472 | $20K |
| 70486 | <1% | 303 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 881 | $18K |
| 82105 | <1% | 1,392 | $17K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 375 | $17K |
| 85610 | <1% | 7,077 | $17K | |
| 86403 | <1% | 1,776 | $16K | |
| 86336 | <1% | 1,299 | $16K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 190 | $16K |
| 86592 | <1% | 5,100 | $16K | |
| 93017 | <1% | 289 | $15K | |
| D2330 | <1% | 270 | $15K | |
| 36600 | <1% | 307 | $14K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,483 | $12K |
| 85730 | <1% | 3,269 | $12K | |
| 82077 | <1% | 1,242 | $12K | |
| 87210 | <1% | 3,308 | $12K | |
| 76642 | <1% | 350 | $12K | |
| 83605 | <1% | 1,798 | $11K | |
| 87070 | <1% | 1,626 | $11K | |
| 82962 | <1% | 5,796 | $11K | |
| 85018 | <1% | 4,767 | $10K | |
| 87081 | <1% | 1,893 | $10K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 277 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 184 | $10K |
| 82550 | <1% | 1,925 | $10K | |
| D1120 | Dental cleaning, child | <1% | 587 | $9K |
| 85660 | <1% | 1,943 | $8K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 105 | $8K |
| 80055 | <1% | 245 | $8K | |
| 86140 | <1% | 1,943 | $8K | |
| 82950 | <1% | 1,916 | $7K | |
| 36430 | <1% | 97 | $7K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 113 | $7K |
| 85379 | <1% | 1,209 | $7K | |
| 73110 | <1% | 188 | $7K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 299 | $7K |
| 88342 | <1% | 52 | $6K | |
| 86920 | <1% | 79 | $6K | |
| 82150 | <1% | 1,222 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 50 | $6K |
| 73502 | <1% | 182 | $6K | |
| 87045 | <1% | 674 | $6K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 47 | $5K |
| 76857 | <1% | 80 | $5K | |
| 12001 | <1% | 56 | $5K | |
| 85652 | <1% | 1,985 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 113 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 295 | $5K |
| 74019 | <1% | 71 | $5K | |
| 82728 | <1% | 550 | $5K | |
| 84703 | <1% | 885 | $5K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 577 | $5K |
| 80047 | <1% | 572 | $5K | |
| 81003 | <1% | 3,179 | $4K | |
| 83540 | <1% | 969 | $4K | |
| 82553 | <1% | 492 | $4K | |
| 85014 | <1% | 2,367 | $4K | |
| 82803 | <1% | 350 | $4K | |
| 83550 | <1% | 710 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 582 | $4K |
| 82248 | <1% | 1,204 | $4K | |
| 87529 | <1% | 73 | $4K | |
| 88304 | <1% | 96 | $4K | |
| 97014 | <1% | 342 | $3K | |
| 82607 | <1% | 400 | $3K | |
| 87101 | <1% | 407 | $3K | |
| 86803 | <1% | 298 | $3K | |
| 82570 | <1% | 998 | $3K | |
| 97162 | <1% | 73 | $3K | |
| 82746 | <1% | 296 | $2K | |
| 82565 | <1% | 835 | $2K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 92 | $2K |
| 85045 | <1% | 743 | $2K | |
| 97113 | <1% | 28 | $2K | |
| 82247 | <1% | 592 | $2K | |
| 84156 | <1% | 991 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 29 | $2K |
| 84153 | <1% | 269 | $2K | |
| 83615 | <1% | 450 | $2K | |
| 80076 | <1% | 261 | $2K | |
| 87899 | <1% | 200 | $2K | |
| 80069 | <1% | 476 | $2K | |
| 72131 | <1% | 40 | $2K | |
| 87430 | <1% | 131 | $2K | |
| 72070 | <1% | 29 | $2K | |
| 71250 | <1% | 42 | $2K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 14 | $1K |
| 84154 | <1% | 170 | $1K | |
| 12002 | <1% | 14 | $1K | |
| C1755 | Catheter, intraspinal | <1% | 1,200 | $1K |
| 72040 | <1% | 29 | $1K | |
| 97116 | <1% | 79 | $1K | |
| 83525 | <1% | 105 | $1K | |
| 84550 | <1% | 300 | $968.77 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 29 | $962.44 |
| 82785 | <1% | 85 | $893.09 | |
| 93971 | <1% | 25 | $867.59 | |
| 81002 | <1% | 371 | $862.62 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 15 | $861.68 |
| 86665 | <1% | 27 | $836.10 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,208 | $781.10 |
| 80143 | <1% | 65 | $780.82 | |
| 73090 | <1% | 16 | $758.76 | |
| 82977 | <1% | 186 | $735.46 | |
| 73590 | <1% | 13 | $689.79 | |
| 73080 | <1% | 19 | $681.58 | |
| 82947 | <1% | 250 | $665.47 | |
| 86141 | <1% | 89 | $598.10 | |
| 81000 | <1% | 217 | $592.64 | |
| 80179 | <1% | 48 | $555.52 | |
| 86696 | <1% | 54 | $540.02 | |
| 86003 | <1% | 57 | $455.90 | |
| 86038 | <1% | 48 | $427.76 | |
| 86695 | <1% | 54 | $427.32 | |
| 83520 | <1% | 32 | $357.12 | |
| 86664 | <1% | 27 | $352.26 | |
| T5999 | Supply, not otherwise specified | <1% | 164 | $289.20 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $281.71 |
| 88300 | <1% | 12 | $244.46 | |
| C1769 | Guide wire | <1% | 1,334 | $235.00 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 377 | $208.91 |
| D3221 | <1% | 260 | $208.91 | |
| 87209 | <1% | 13 | $187.69 | |
| 82784 | <1% | 12 | $175.77 | |
| 80050 | General health panel | <1% | 121 | $170.66 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 553 | $161.24 |
| 87425 | <1% | 15 | $146.61 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,801 | $125.88 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,210 | $120.93 |
| 84100 | <1% | 52 | $120.50 | |
| 86677 | <1% | 13 | $119.60 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 43 | $116.99 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,487 | $110.07 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 474 | $99.20 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,641 | $93.27 |
| 87177 | <1% | 13 | $92.92 | |
| 86430 | <1% | 20 | $82.97 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,330 | $62.38 |
| 86769 | <1% | 23 | $37.92 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,106 | $35.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,907 | $33.40 |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 622 | $29.73 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 852 | $28.05 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 36 | $20.25 |
| 99152 | <1% | 397 | $15.20 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 5,582 | $10.67 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 893 | $5.80 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 461 | $5.70 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,495 | $1.60 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 107 | $0.45 |
| J2704 | Injection, propofol, 10 mg | 0% | 5,139 | $0.00 |
| 96376 | 0% | 661 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 1,240 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 3,150 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 42 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 572 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 62 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 303 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 616 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 147 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 118 | $0.00 |
| 94760 | 0% | 85 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 110 | $0.00 |
| 64494 | 0% | 112 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 122 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 33 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 138 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 32 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 41 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 14 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 15 | $0.00 |
| 90715 | 0% | 814 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 458 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 113 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 486 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 551 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 57 | $0.00 |
| 84112 | 0% | 18 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 249 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 128 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 32 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 43 | $0.00 |
| 64495 | 0% | 109 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 35 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 66 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 36 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 0% | 16 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 14 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 12 | $0.00 |
| 64636 | 0% | 39 | $0.00 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 14 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 13 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.